S.A. Novo Nordisk Pharma N.V. SA
82.6 FTES.A. Novo Nordisk Pharma N.V. reported revenue of €197.1m for the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026), with 82.6 full-time equivalents.
By total assets for 2025, S.A. Novo Nordisk Pharma N.V. ranks among the 50 largest of the 970 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of S.A. Novo Nordisk Pharma N.V. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +53 % Equity +23 % Total assets +51 % Headcount (avg FTE) +4 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
S.A. Novo Nordisk Pharma N.V.'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 08 Aug 2025
- Year ended 31 Dec 2023filed on 23 May 2024
- Year ended 31 Dec 2022filed on 07 Jun 2023
- Year ended 31 Dec 2021filed on 13 May 2022
S.A. Novo Nordisk Pharma N.V.'s financial analysis
- Solvency1.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of S.A. Novo Nordisk Pharma N.V.
S.A. Novo Nordisk Pharma N.V.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0414.695.586
- VAT number
- BE0414695586
- Peppol
- Registered · 0208:0414695586 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Sep 1974
- Registered office
- 1702 Dilbeek
- Size
- Medium · 82.6 FTE
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
S.A. Novo Nordisk Pharma N.V. (SA) has been based in Dilbeek since 1974, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €197.1m, a net profit of €5.68m and equity of €1.07m. With 82.6 full-time equivalents, it is a medium-sized enterprise by headcount.
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to S.A. Novo Nordisk Pharma N.V.
Companies in the same business, of comparable size and area, outside its group.
- Servier Benelux Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €61.5m
- V.M.D. Manufacture of pharmaceutical preparations Arendonk · balance sheet €28.5m
- PHOENIX Pharma Belgium Manufacture of pharmaceutical preparations Woluwe-Saint-Lambert · balance sheet €235.4m
- Roche Manufacture of pharmaceutical preparations Anderlecht · balance sheet €164.7m
- KELA - Kempisch Laboratorium - Kela Laboratoria Manufacture of pharmaceutical preparations Hoogstraten · balance sheet €63.2m
- Opella Healthcare Belgium NV/SA Manufacture of pharmaceutical preparations Machelen (Brab.) · balance sheet €32.3m
- Tilman Manufacture of pharmaceutical preparations Somme-Leuze · balance sheet €43.2m
- Alcon Laboratories Belgium Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €107.2m
Frequently asked questions about S.A. Novo Nordisk Pharma N.V.
What is the revenue of S.A. Novo Nordisk Pharma N.V.?
According to the 2025 annual accounts filed with the NBB, the revenue of S.A. Novo Nordisk Pharma N.V. amounts to 197,132,669 €.
What is the VAT number of S.A. Novo Nordisk Pharma N.V.?
In Belgium, the VAT number is the company number prefixed with BE: BE0414695586 for S.A. Novo Nordisk Pharma N.V., if the company is VAT-registered. Its company number (CBE) is 0414.695.586.
Where is the registered office of S.A. Novo Nordisk Pharma N.V.?
According to the CBE register, the registered office of S.A. Novo Nordisk Pharma N.V. is in 1702 Dilbeek.
What is the equity of S.A. Novo Nordisk Pharma N.V.?
At the close of the 2025 financial year, the equity of S.A. Novo Nordisk Pharma N.V. amounts to 1,071,803 €, a solvency of 1.6% of total assets.
How many people work at S.A. Novo Nordisk Pharma N.V.?
82.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages S.A. Novo Nordisk Pharma N.V.?
The register lists 5 active mandates at S.A. Novo Nordisk Pharma N.V.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is S.A. Novo Nordisk Pharma N.V. within its sector?
By total assets for 2025, S.A. Novo Nordisk Pharma N.V. ranks among the 50 largest of the 970 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of S.A. Novo Nordisk Pharma N.V.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →